LONDON--(Marketwire - April 30, 2009) -
| Highlighted Links |
RNS Market News |
Smith & Nephew appoints Roger Teasdale as Advanced Wound Management
President
30 April 2009
Smith & Nephew plc (NYSE: SNN; LSE: SN) announces today the appointment
of Roger Teasdale as President of its Advanced Wound Management
business.
Mr Teasdale, 42, has been with Smith & Nephew for 20 years and has
experience in driving top line growth and expanding margins. He has
excellent experience in sales, marketing and executive leadership. Most
recently he served as Senior Vice President Advanced Woundcare and was
also, at the same time, Interim President North America for a year.
Dave Illingworth, Chief Executive Officer of Smith & Nephew, commenting
on this appointment said, "Smith & Nephew is fortunate to have in Roger
an excellent leader who can lead our Advanced Wound Management
Division. With his long experience in the advanced woundcare market
and his recent experience in the US Roger will be able to continue the
development of the business and the pursuit of its strategy; to expand
the business in the US, improve margins and build a significant market
share in the Negative Pressure Wound Therapy market. Roger will be
instrumental in helping us build an even stronger leadership position
in the advanced woundcare marketplace. I look forward to his
contributions."
Mr Teasdale will start his new position on 1 May 2009 and will be
based at the Advanced Wound Management Division headquarters in Hull as
well as spending a substantial portion of his time at the US Advanced
Wound Management headquarters in St Petersburg Florida.
Mr Teasdale is replacing Joe Woody who is leaving the Company after 3
years as President of the Advanced Woundcare division to pursue other
business opportunities in the US. Dave Illingworth, Chief Executive
Officer of Smith & Nephew, commenting said, "Mr Woody has made an
outstanding contribution to Smith & Nephew both in Advanced Wound
Management and in his previous role in Orthopaedics. He leaves
Advanced Wound Management with a strong platform for future growth".
Mr Teasdale received his BA (Hons) degree in Accounting and Management
Control from Sheffield University. He currently resides in northern
England with his wife and two children.
Enquiries
Investors
Liz Hewitt Tel: +44 (0) 20 7401 7646
Smith & Nephew
Group Director Corporate Affairs
Media
Jon Coles Tel: +44 (0) 20 7404 5959
Brunswick - London
Cindy Leggett-Flynn Tel: +1 (212) 333 3810
Brunswick - New York
About Us
Smith & Nephew is a global medical technology business, specialising in
Orthopaedics, including Reconstruction, Trauma and Clinical Therapies;
Endoscopy and Advanced Wound Management. Smith & Nephew is a global
leader in arthroscopy and advanced wound management and is one of the
leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The
Company prides itself on the strength of its relationships with its
surgeons and professional healthcare customers, with whom its name is
synonymous with high standards of performance, innovation and trust.
The Company operates in 32 countries around the world. Annual sales in
2008 were nearly USD3.8 billion.
This information is provided by RNS
The company news service from the London Stock Exchange
END
